CALA

Calithera Biosciences Inc
0.20
0.00 (0.00%)

Calithera Biosciences Inc. (CALA) Fundamentals

Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm functions through the region of the US. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its lead product candidate is CB-839, an inhibitor of glutaminase for the treatment of solid tumors. Its other product candidate, CB-1158, is being developed for hematology and oncology indications.
SHARE INFORMATION
Market Cap$ 851,420
Shares Outstanding4,865,257
Float4,677,545
Percent Float96.14%
Short Interest417,277.00
Short Percent Float8.6%
Short Interest Ratio0.78
Short Interest Date2023-01-13
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 9,750,000
Latest Fiscal EPS$ -31.18
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions89
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months81,740
Institutional Holdings Percent47.7%
Institutional Sold Previous 3 Months386,553
Insider Holdings Date2023-01-31
Insider Bought Previous 3 Months-
Insider Holdings Percent13.7
Insider Sold Previous 3 Months122,751
Insider Shares Owned667,808
TRADING INFO
52 Week High$ 13.38
52 Week Low$ 0.11
52 Week High Change$ -98.30
21 Day Moving Average$ 0.725
21 Day Extended Moving Average$ 0.767127
50 Day Moving Average$ 1.5739
50 Day Extended Moving Average$ 1.412
200 Day Moving Average$ 2.9819
200 Day Extended Moving Average$ 5.274
10 Day Average Volume463,664
20 Day Average Volume787,326
30 Day Average Volume556,676
50 Day Average Volume359,476
Alpha-0.058825
Beta1.0413
Standard Deviation0.256809
R20.047965
7 Day Price Change$ -0.205
7 Day Percent Change-53.95%
21 Day Price Change$ -0.3513
21 Day Percent Change-66.75%
30 Day Price Change$ -2.91
30 Day Percent Change-94.32%
Month to Date Price Change$ -0.235
Month to Date Percent Change-57.32%
Quarter to Date Price Change$ -3.09
Quarter to Date Percent Change-94.63%
180 Day Price Change$ -3.11
180 Day Percent Change-94.66%
200 Day Price Change$ -2.42
200 Day Percent Change-93.24%
Year to Date Price Change$ -3.09
Year to Date Percent Change-94.63%

Calithera Biosciences Inc. (CALA) Key Ratios

PROFITABILITY
EBIT Margin-810.2%
EBITDA Margin-806.3%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.20
Total Debt To Equity0.50
Int Coverage-11,323.90
Current Ratio3.80
Leverage Ratio9.60
Quick Ratio3.70
Long Term Debt To Capital0.02
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ -8,851,581
Price to Sales0.00
Price to Free Cash0.00
PE High Last 5 Years-3.90
Price To Book0.20
Price To Cash Flow14.70
PE Low Last 5 Years-4.20
Price to Tangible Book0.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-131.54
Return on Equity-213.00
Return on Capital-199.32

Calithera Biosciences Inc. (CALA) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOSusan M. Molineaux
Emplyoees63
Last AuditUE
CIK0001496671
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address343 Oyster Point Boulevard
Suite 200
South San Francisco, CA 94080
Websitehttps://www.calithera.com
Facsimile+1 650 588-5272
Telephone+1 650 870-1000
Emailir@calithera.com


Your Recent History
NASDAQ
CALA
Calithera ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.